- Created: February 18, 2011
- Type: Conference Group
- Members: 33
- Owner: Congress B.
- Website: http://www.tatcongress.org
The “International Congress on Targeted Anticancer Therapies” (TAT) is a series of congresses, held annually in March, aimed at promoting scientific exchange between professionals involved in the discovery and development of new targeted agents for cancer therapy. The TAT congress series is of importance for everyone in academia, industry and governmental agencies involved in the discovery and evaluation (preclinical and clinical) of new molecular targets and agents for cancer therapy. By virtue of their focus on the early phases of clinical development, TAT congresses are of particular importance to phase 1 and 2 clinical investigators, scientists conducting preclinical studies and translational research of drugs in the early phases of clinical development, project and program directors in charge of clinical development programs in industry and the CRO environment, and new business development and licensing professionals.
